QIAGEN N.V.

Qiagen N.V. provides "sample to insight" solutions globally, transforming biological samples into molecular insights for the molecular diagnostics and life sciences sectors. The company offers sample technology consumables, including nucleic acid stabilization and purification kits for various sample materials, supporting manual and automated processing for genotyping, gene expression, and viral and bacterial analysis. These consumables utilize silica membranes and magnetic bead technologies. It also provides secondary sample technology consumables for nucleic acid purification and instruments for nucleic acid purification and quality control. Qiagen's product portfolio includes Immune response consumables, such as interferon-gamma release assays for TB testing, and assays for post-transplant testing and viral load monitoring. For oncology and sexual and reproductive health, it offers assays for prenatal testing, detection of sexually transmitted diseases and HPV, and analysis of genomic variants. The company also provides "sample to insight" instruments for one-step molecular analysis of hard-to-diagnose syndromes and integrated PCR testing. Additionally, Qiagen offers research PCR consumables, including quantitative PCR, reverse transcription, and combination kits for gene expression, genotyping, and gene regulation, compatible with QIAGEN instruments. Its human ID/forensics assay consumables include short tandem repeat assays for human identification and assays for food contamination. The company provides PCR instruments, such as digital PCR and qPCR solutions, along with developed and configured enzymes and PCR solutions. Further offerings include NGS gene panels, library prep kits and components, whole genome amplification, DNA methylation analysis, QIAGEN consumables and instruments, bioinformatics solutions, sequence-based assays, forensic genetic genealogy services, and software-as-a-service. The company was founded in 1984 and is headquartered in Venlo, the Netherlands.